Dismisses link between suicidal behaviour and ADHD drugs

Dismisses link between suicidal behaviour and ADHD drugs

A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).

"Our work in several ways shows that most likely there is no link between treatment with ADHD drugs and an increased risk of suicide attempts or suicide. The results rather indicate that ADHD drugs may have a protective effect," says Henrik Larsson, researcher at the Department of Medical Epidemiology and Biostatistics, who headed the study.

Earlier research has indicated that ADHD drug treatment would increase the occurrence of . However, these studies have been small scale and/or the methods used have been limited, which make the results uncertain. To gain clarity in this matter, researchers at Karolinska Institutet have now used national patient registers to identify all patients in Sweden diagnosed with ADHD between 1960 and 1996; a total of 37,936 individuals. These people were then followed over the period 2006-2009, in terms of drug treatment and events that could be linked to suicide attempts and suicide.

Among other things, the study compared the rate of while the patients were receiving ADHD medication, as compared with the rate for the same patients while not receiving medication. Using this design the researchers were able to determine that there was no evidence to support that ADHD therapy would increase the risk of /suicide. One strong point of the study now being published is that all the individuals were compared to themselves, as this allowed the researchers to take into account the differences between those taking the drugs and those who do not.

"Many epidemiological studies on the risks related to drugs fail to adjust for the differences between individuals who take the drugs and those who do not. This is a critical limitation given that the individuals on medication are usually more severely ill than the others," says Henrik Larsson.

More information: "Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study", Qi Chen, Arvid Sjölander, Bo Runeson, Brian M D'Onofrio, Paul Lichtenstein & Henrik Larsson, British Medical Journal, online 18 June 2014, doi=10.1136/bmj.g3769 , BMJ 2014; 348:g3769.

add to favorites email to friend print save as pdf

Related Stories

ADHD medication saves lives on the road

Jan 29, 2014

New research from Karolinska Institutet in Sweden shows that medication used to treat ADHD in adult men can save lives on the road. According to a large registry study, which is now being published in the scientific journal ...

ADHD drug effective for people with dependency

Oct 14, 2013

People with ADHD and substance dependence rarely respond as they should to ADHD medication. A randomised study from Karolinska Institutet now shows that it is possible to obtain the desired efficacy by administering the drug ...

MRI technique may help prevent ADHD misdiagnosis

Jun 17, 2014

Brain iron levels offer a potential biomarker in the diagnosis of attention deficit hyperactivity disorder (ADHD) and may help physicians and parents make better informed treatment decisions, according to ...

ADHD treatment associated with lower smoking rates

May 12, 2014

Treating attention deficit hyperactivity disorder (ADHD) with stimulant medication may reduce smoking risk, especially when medication is taken consistently, according to an analysis led by researchers at ...

Recommended for you

Popular pain killer linked to behavioural disorders

Sep 26, 2014

Research at the University of Auckland has reinforced the discovery of a link between mothers taking a common pain killer during pregnancy and their children developing behavioural problems.

User comments